Navigation Links
Genitourinary in Medical News

Medivation Announces Upcoming Presentation of New MDV3100 Data in Patients With Advanced Prostate Cancer at 45th American Society of Clinical Oncology Annual Meeting

... Annual Meeting in Orlando, Fla. Oral Abstract Session: genitourinary (Prostate) Cancer Abstract Title: "Antitumor Activity of ... principal investigator, chief of the genitourinary Oncology Service and the D. Wayne Calloway ...

Drug shows activity in men with advanced prostate cancer

... who received the drug at higher doses were recently reported at the ASCO genitourinary Cancers Symposium in February 2009 (see abstract: ... encouraging," said Howard Scher, MD, a study co-author and Chief of the genitourinary Oncology Service at MSKCC. "I am looking forward to continuing the study ...

New Prostate Cancer Drug May Hold Promise

... those androgens on the tumor cells, said Dr. Howard I. Scher, chief of the genitourinary oncology service at Memorial Sloan-Kettering Cancer Center in New York ... cancer . SOURCES: Howard I. Scher, M.D., chief, genitourinary oncology service, Memorial Sloan-Kettering Cancer Center, New York City; ...

Tests Might Diagnose, Predict Prostate Cancer

... developing the disease. Both studies were presented Tuesday at the 2009 genitourinary Cancers Symposium in Orlando, Fla., sponsored by the American Society of ... Memorial Sloan-Kettering Cancer Center, New York City; presentations, 2009 genitourinary Cancers Symposium sponsored by American Society of Clinical Oncology, ...

Hormone Therapy Only Helps Some Older Men With Prostate Cancer

... on the gentleman's health," said Dr. Anthony V. D'Amico, chief of genitourinary oncology at Brigham and Women's Hospital in Boston. His report is ... SOURCES: Anthony V. D'Amico, M.D., chief, genitourinary oncology, Brigham and Women's Hospital, Boston; Durado Brooks, director, ...

Aspirin, Hormone Therapy Combo Can Shorten Lives of Prostate Cancer Patients

... said lead researcher Dr. Anthony V. D'Amico, chief of the division of genitourinary radiation oncology at Brigham & Women's Hospital and the Dana-Farber ... SOURCES: Anthony V. D'Amico, M.D., Ph.D., chief, division of genitourinary radiation oncology, Brigham & Women's Hospital and Dana-Farber Cancer ...

PSA Testing Still Valuable for Prostate Cancer

... treatment for prostate cancer, said Slovin, an assistant member of the genitourinary Oncology Service at Memorial Sloan-Kettering Cancer Center, and an ... for the National Prostate Cancer Coalition, an assistant member of the genitourinary Oncology Service at Memorial Sloan-Kettering Cancer Center, and an ...

Blood transfusion study: Less is more

... percent, and blood use among men varied from about 50 percent to 100 percent. Transfusions with donor blood were associated with infections of the genitourinary system, respiratory tract, bloodstream, digestive tract and skin, the study said. The risk of death in the hospital was nearly 5 times greater ...

Combination Therapy Best for Aggressive Prostate Cancer

... supporting this treatment method alone based on survival data from randomized trials is lacking," lead researcher Dr. Anthony D'Amico, chief of genitourinary radiation oncology at Brigham and Women's Hospital in Boston, said in a news release from the hospital. "In order to get the highest cure rate for ...

MDOUTLOOK(R) Quick Polls Report on Clinical Integration of Key Oncology Developments Following ASCO 2009

... than 43,000 cancer treaters globally and covers all major and smaller oncology areas, including lung cancer, breast cancer, gastrointestinal cancer, genitourinary cancer, gynecological cancer, hematological malignancies, and melanoma. MDOUTLOOK is being launched in other complex diseases, such as Rheumatoid ...

BD Announces CE Marking of BD ProbeTec™ Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae

... 3 Health Protection Agency. (2007, July, 20). Sexually transmitted infection diagnoses and services provided in genitourinary medicine clinics in the country-region in 2006. Retrieved January 5, 2009 from http://www.hpa.org.uk/hpr/archives/2007/news2007/news2907.htm 4 ...

Gene Test Helps Detect Prostate Cancer

... could spare tens of thousands of men from undergoing an unnecessary biopsy," study author Dr. William K. Oh, clinical director of the Lank Center for genitourinary Oncology at the Dana-Farber Cancer Institute in Boston, said in a news release from the organization. "However, until we can verify our findings, ...

New blood test greatly reduces false-positives in prostate cancer screening

... results underscores the need for a more accurate method for detecting prostate cancer, said Oh, who is the clinical director of the Lank Center for genitourinary Oncology at Dana-Farber. The two-year study involved 484 participants. The group comprised 204 men with known prostate cancer, 110 men with benign ...

Poniard Pharmaceuticals Announces Positive Efficacy and Safety Data From Phase 2 Clinical Trial of Picoplatin in Men With Metastatic Prostate Cancer

... with docetaxel and prednisone is active as first-line therapy for CPRC," said William K. Oh, M.D., clinical director of the Lank Center for genitourinary Oncology at the Dana Farber Cancer Institute and associate professor, Harvard Medical School . "There is no platinum-based chemotherapy approved for ...

Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM)

... warfarin or other drugs that affect coagulation. Male patients with a history of obstructive uropathies may experience higher rates of genitourinary adverse events. Savella is unlikely to be involved in clinically significant pharmacokinetic drug interactions. Pharmacodynamic interactions of ...

M. D. Anderson launches graduate program in cancer metastasis

... as a separate discipline," said program organizer Gary E. Gallick, Ph.D., professor and director of education in M. D. Anderson's Department of genitourinary Medical Oncology and a member of the GSBS faculty. UT System allocated $485,250 to the metastasis program over three years, one of only seven ...

Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM)

... aspirin, warfarin or other drugs that affect coagulation. Male patients with a history of obstructive uropathies may experience higher rates of genitourinary adverse events. Savella is unlikely to be involved in clinically significant pharmacokinetic drug interactions. Pharmacodynamic interactions of ...

UT nanoscientist gets $7 million DoD Innovator Award for breast cancer research

... of Human Diseases. Collaborating investigators from the UT M. D. Anderson Cancer Center include: Renata Pasqualini, Ph.D., professor of genitourinary medical oncology; Gabriel Lopez-Berestein, M.D., professor of experimental therapeutics; Anil Sood, M.D., professor of gynecologic oncology; Funda ...

ACORN's Success in Delivering Top Quality Research Portfolio to Community-Based Oncology Practices Presented at Annual Investigator Meeting

... Henry, MD, Pennsylvania Oncology Hematology Associates, Philadelphia, PA, Supportive Care Trials; and Brad Somer, MD, The West Clinic, Memphis, TN, genitourinary Trials. The ACORN Network seeks to make clinical research an integral part of community-based cancer care by giving every patient an equal ...

Proepithelin encourages cell growth and migration in prostate cancer

... markers to identify which of patients are likely to progress to metastatic disease. Results of this study will also be presented at the 2009 ASCO genitourinary Cancers Symposium. ...

Medivation to Host Conference Call and Slide Presentation at 4:30 p.m. EST Wednesday, February 25, to Discuss New MDV3100 Efficacy and Safety Data From Trial in Castration-Resistant Prostate Cancer Patients

... antagonist MDV3100 in castration-resistant prostate cancer patients. Howard Scher, M.D., principal investigator of the trial and chief of the genitourinary Oncology Service and the D. Wayne Calloway Chair in Urologic Oncology at Memorial Sloan-Kettering Cancer Center, will participate in the ...

AUA Annual Scientific Meeting features more new research than ever before

... research on topics in urology, including prostate, bladder and kidney cancer; benign prostatic hyperplasia (BPH, or enlarged prostate); and other genitourinary diseases and conditions. Researchers are also expected to present new information regarding the upcoming AUA guidance documents on ...

Forest and Cypress Announce FDA Approval of Savella(TM) for the Management of Fibromyalgia

... warfarin or other drugs that affect coagulation. Male patients with a history of obstructive uropathies may experience higher rates of genitourinary adverse events. Savella is unlikely to be involved in clinically significant pharmacokinetic drug interactions. Pharmacodynamic interactions of ...

Why bladder cancer is deadlier for some

... in the ways these groups are treated," said Messing, who is professor of Urology and Oncology as well as leader of the Prostate Cancer and genitourinary Oncology team at the James P. Wilmot Cancer Center. To do the study, scientists analyzed the records of more than 100,000 patients who were ...

Why Bladder Cancer Is Deadlier for Some

... in the ways these groups are treated," said Messing, who is professor of Urology and Oncology as well as leader of the Prostate Cancer and genitourinary Oncology team at the James P. Wilmot Cancer Center. To do the study, scientists analyzed the records of more than 100,000 patients who were ...

Poniard Pharmaceuticals Provides 2009 Clinical Data Goals for Picoplatin

... Prostate Cancer -- Present data from the ongoing Phase 2 trial of picoplatin in patients with metastatic HRPC at ASCO's 2009 genitourinary Cancers Symposium on February 27 in Orlando, Fla. This study is evaluating the efficacy and safety of picoplatin administered every ...

MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results

... for treatment of the following infections: respiratory tract infections, otitis media, skin and skin structure infections, bone infections, and genitourinary tract infections. More information on Keflex and prescribing information are available at ...

MiddleBrook Pharmaceuticals Reports Second Quarter 2008 Results

... for treatment of the following infections: respiratory tract infections, otitis media, skin and skin structure infections, bone infections, and genitourinary tract infections. More information on Keflex and prescribing information are available at ...

Experimental agent blocks prostate cancer in animal study

... inhibit prostate cancer development in an aggressive model of the disease, says coauthor Dr. Steven Clinton, director of the prostate and genitourinary oncology clinic at Ohio States James Cancer Hospital and Solove Research Institute. We hope to see this agent in clinical trials soon and ultimately ...

NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO

... in hormone refractory prostate cancer (HRPC). NYU Cancer Institutes Anna Ferrari, M.D., associate professor of medicine; co-program leader for the genitourinary cancer research program, at NYU Langone Medical Center NYU Langone Medical Center researchers present a new strategy that may lead to new ...

Fox Chase Cancer Center's Ning Wong receives ASCO Cancer Foundation Career Development Award

... holds a dual appointment as an associate member of the Center's divisions of medical science and population science. Her clinical interests include genitourinary malignancies such as kidney, bladder, prostate and testicular cancers. Wong also conducts health services research including cost-effectiveness ...

MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results

... for treatment of the following infections: respiratory tract infections, otitis media, skin and skin structure infections, bone infections, and genitourinary tract infections. More information on Keflex and prescribing information are available at ...

Cell Genesys Reports Fourth Quarter and Year-End 2007 Results

... antibody responses are associated with patient survival. These results were presented at the American Society of Clinical Oncology's genitourinary Cancer Symposium held in mid-February. -- Announced in January 2008 that the Independent Data Monitoring Committee (IDMC) for VITAL-1, the ...

QED International Associates Announces Changes to the HealthShares(TM) GI/Gender Health Index

... to, gastrointestinal disorders such as gastroesophageal reflux disease, heartburn, irritable bowel syndrome, Crohn's Disease and ulcerative colitis; genitourinary disorders such as overactive bladder, urge incontinence, stress incontinence and urinary tract infection; and gender health matters including sexual ...

Study identifies which men are likely to have persistent prostate cancer

... have disease after treatment. With this knowledge, we can better tailor treatment. In the study presented by Buyyounouski today at the 2008 genitourinary Cancers Symposium in San Francisco, researchers compared prostate biopsies taken before treatment with those taken again two years after treatment. ...

OHSU cancer institute researcher discovers new predictor of prostate cancer recurrence

... Recurrence, will be presented as a poster on Thursday, Feb. 14, from 11:30 a.m. to 12:30 p.m. at the 2008 American Society of Clinical Oncology genitourinary Symposium in San Francisco. In this study, the largest of its kind examining DNA methylation changes and prostate cancer recurrence, the research ...

Many Prostate Cancers Will Not Need Treatment

... option is their personal preference," Lu-Yau said. She presented the findings to reporters at a special teleconference Tuesday, part of the 2008 genitourinary Cancers Symposium taking place in San Francisco. The question of whether to treat or not treat prostate cancer has long absorbed experts. ...

Kidney Cancer Drug Linked to Higher Rate of Heart Problems

... to administer this medication more safely for patients whose benefits clearly outweigh the risks." Telli was to present the findings at the 2008 genitourinary Cancers Symposium in San Francisco. She spoke to reporters at a Tuesday teleconference. Other experts agreed that monitoring of patients on Sutent ...

NewYork-Presbyterian/Weill Cornell creates world-class cancer center

... an excellent cancer program into a renowned cancer center, investing in areas where we have historic strength -- such as lymphoma, lung cancer, genitourinary and preventive oncology -- while establishing new programs that can be uniquely identified with NewYork-Presbyterian/Weill Cornell," says Dr. Herbert ...

MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results

... for treatment of the following infections: respiratory tract infections, otitis media, skin and skin structure infections, bone infections, and genitourinary tract infections. More information on Keflex and prescribing information are available at ...
Other Contents
(Date:7/10/2014)... the main organization of the International Science and Business ... group of researchers, led by professor Won Do Heo, ... optogenetics that can remotely control specific receptors by light. ... has succeeded with neuronal differentiation inducement. , The most ... only light to activate neuronal functions without the need ...
(Date:7/10/2014)... vegetable oil found in your popcorn or soap might not ... even worse, according to an analysis in the Cell Press ... growing demand for vegetable oil has already led to the ... trouble for orangutans in particular. If guidelines are not put ... large-scale industrial plantations from Asia into Africa will be bad ...
(Date:7/10/2014)... the open ocean as a microbial megacity, teeming with ... of water, hundreds of types of bacteria can be ... these ocean microbes have their own daily cyclesnot unlike ... wake up, commute, work, and eat at the same ... Light-loving photoautotrophsbacteria that need solar energy to help them ...
Breaking Biology News(10 mins):New optogenetic tool for controlling neuronal signalling by blue light 2Hunger for vegetable oil means trouble for Africa's great apes 2New research finds ocean's most abundant organisms have clear daily cycles 2New research finds ocean's most abundant organisms have clear daily cycles 3
(Date:7/10/2014)... announcement that the "Mississippi Baby," believed to have been ... have detectable levels of the virus, the Elizabeth Glaser ... but remains hopeful that the scientific breakthrough that allowed ... than two years will continue to help researchers understand ... , "Although we had high hopes that the ...
(Date:7/10/2014)... on aggression, who research issues ranging from child abuse ... Meeting of the International Society for Research on Aggression ... Georgia State University is hosting the prestigious world meeting, ... , "We are excited to be bringing together leading ... help produce fresh ideas about the causes, consequences and ...
(Date:7/10/2014)... the amount of alcoholic beverages consumed, even for ... reduced risk of coronary heart disease, lower body ... a new multi-center study published in The ... of Medicine at the University of Pennsylvania. The ... suggest that consuming light-to-moderate amounts of alcohol (0.6-0.8 ...
(Date:7/10/2014)... known as the "Mississippi baby" an infant seemingly cured ... a prolonged remission of HIV infection in The New ... of HIV after more than two years of not taking ... HIV specialist and researchers involved in the case. ... this young child, the medical staff involved in the child,s ...
(Date:7/10/2014)... students looking to bump up their grade point averages ... time in a library or study hall, but in ... that students who were members of the recreational sports ... and sophomore years had higher GPAs than those who ... with memberships stayed in school longer. An increase of ...
Breaking Medicine News(10 mins):Health News:Despite setback, 'Mississippi Baby' represents significant breakthrough in effort to end AIDS 2Health News:Georgia State hosts national conference on aggression 2Health News:Georgia State hosts national conference on aggression 3Health News:New study shows drinking alcohol provides no heart health benefit 2Health News:'Mississippi Baby' now has detectable HIV, researchers find 2Health News:'Mississippi Baby' now has detectable HIV, researchers find 3Health News:Want a higher GPA in college? Join a gym 2
Other TagsOther Tags